RGNT
$3.37
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen fo...
Recent News
Regentis Biomaterials (RGNT) Appoints New CFO/CBO as GelrinC Nears Commercial Launch
Regentis Biomaterials Ltd. (NYSEAMERICAN:RGNT) is one of the best up and coming penny stocks to buy. On February 4, Regentis Biomaterials appointed Ori Gon as Chief Financial Officer and Chief Business Officer to lead the company’s financial strategy and commercial development. Gon joined the regenerative medicine firm as its lead product, GelrinC, nears commercial launch […]
Sector Update: Health Care Stocks Slide Late Afternoon
Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index and the Health
Sector Update: Health Care Stocks Softer in Afternoon Trading
Health care stocks declined Thursday afternoon with the NYSE Health Care Index dropping 0.5% and the